Understanding lactic acidosis in paracetamol (acetaminophen) poisoning

British Journal of Clinical Pharmacology

Volumn 71, Issue 1, 2011, Pages 20-28

  Shah, Anoop D ^a   Wood, David M ^a,b   Dargan, Paul I ^a,b  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Acetaminophen; Lactate; Lactic acidosis; Overdose; Paracetamol; Prognosis

Indexed keywords

ACETYLCYSTEINE; BICARBONATE; DRUG METABOLITE; LACTIC ACID; PARACETAMOL;

ARTICLE; DRUG INTOXICATION; HUMAN; LACTATE BLOOD LEVEL; LACTIC ACIDOSIS; LIVER CLEARANCE; LIVER TOXICITY; MITOCHONDRIAL RESPIRATION; PRIORITY JOURNAL; PROGNOSIS;

ACETAMINOPHEN; ACIDOSIS, LACTIC; FEMALE; HUMANS; LIVER FAILURE, ACUTE; MALE; OVERDOSE; PROGNOSIS;

EID: 78650010368     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2010.03765.x     Document Type: Article

References (87)

1. Sheen CL, Dillon JF, Bateman DN, Simpson KJ, Macdonald TM. Paracetamol toxicity: epidemiology, prevention and costs to the health-care system. QJM 2002; 95: 609-19.
2. Wells C. Deaths related to drug poisoning in England and Wales, 2008. Health Stat Q 2009; 43: 48-55.
3. Khashab M, Tector AJ, Kwo PY. Epidemiology of acute liver failure. Curr Gastroenterol Rep 2007; 9: 66-73.
4. Jones A. Over-the-counter analgesics: a toxicology perspective. Am J Ther 2002; 9: 245-57.
5. Nourjah P, Ahmad SR, Karwoski C, Willy M. Estimates of acetaminophen (paracetamol)-associated overdoses in the united states. Pharmacoepidemiol Drug Saf 2006; 15: 398-405.
6. Roth B, Woo O, Blanc P. Early metabolic acidosis and coma after acetaminophen ingestion. Ann Emerg Med 1999; 33: 452-6.
7. Mendoza CD, Heard K, Dart RC. Coma, metabolic acidosis and normal liver function in a child with a large serum acetaminophen level. Ann Emerg Med 2006; 48: 637.
8. Bernal W, Donaldson N, Wyncoll D, Wendon J. Blood lactate as an early predictor of outcome in paracetamol-induced acute liver failure: a cohort study. Lancet 2002; 359: 558-63.
9. Macquillan GC, Seyam MS, Nightingale P, Neuberger JM, Murphy N. Blood lactate but not serum phosphate levels can predict patient outcome in fulminant hepatic failure. Liver Transpl 2005; 11: 1073-9.
10. Fannin RD, Russo M, O'Connell TM, Gerrish K, Winnike JH, Macdonald J, Newton J, Malik S, Sieber SO, Parker J, Shah R, Zhou T, Watkins PB, Paules RS. Acetaminophen dosing of humans results in blood transcriptome and metabolome changes consistent with impaired oxidative phosphorylation. Hepatology 2009; 51: 227-36.
11. Nazareth WM, Sethi JK, McLean AE. Effect of paracetamol on mitochondrial membrane function in rat liver slices. Biochem Pharmacol 1991; 42: 931-36.
12. Strubelt O, Younes M. The toxicological relevance of paracetamol-induced inhibition of hepatic respiration and ATP depletion. Biochem Pharmacol 1992; 44: 163-70.
13. Porter KE, Dawson AG. Inhibition of respiration and gluconeogenesis by paracetamol in rat kidney preparations. Biochem Pharmacol 1979; 28: 3057-62.
14. Bajt ML, Knight TR, Lemasters JJ, Jaeschke H. Acetaminophen-induced oxidant stress and cell injury in cultured mouse hepatocytes: protection by N-acetyl cysteine. Toxicol Sci 2004; 80: 343-9.
15. Martin FL, McLean AE. Adenosine triphosphate (ATP) levels in paracetamol-induced cell injury in the rat in vivo and in vitro. Toxicology 1995; 104: 91-7.
16. Esterline RL, Ji S. Metabolic alterations resulting from the inhibition of mitochondrial respiration by acetaminophen in vivo. Biochem Pharmacol 1989; 38: 2390-2.
17. Burcham PC, Harman AW. Mitochondrial dysfunction in paracetamol hepatotoxicity: in vitro studies in isolated mouse hepatocytes. Toxicol Lett 1990; 50: 37-48.
18. Kon K, Kim JS, Jaeschke H, Lemasters JJ. Mitochondrial permeability transition in acetaminophen-induced necrosis and apoptosis of cultured mouse hepatocytes. Hepatology 2004; 40: 1170-9.
19. Jaeschke H. Glutathione disulfide formation and oxidant stress during acetaminophen-induced hepatotoxicity in mice in vivo: the protective effect of allopurinol. J Pharmacol Exp Ther 1990; 255: 935-41.
20. Jaeschke H, Bajt ML. Intracellular signaling mechanisms of acetaminophen-induced liver cell death. Toxicol Sci 2006; 89: 31-41.
21. Landin JS, Cohen SD, Khairallah EA. Identification of a 54-kDa mitochondrial acetaminophen-binding protein as aldehyde dehydrogenase. Toxicol Appl Pharmacol 1996; 141: 299-307.
22. Dart RC, Bailey E. Does therapeutic use of acetaminophen cause acute liver failure? Pharmacotherapy 2007; 27: 1219-30.
23. Gonzalez FJ. The 2006 Bernard B. Brodie award lecture. CYP2E1. Drug Metab Dispos 2007; 35: 1-8.
24. Jaeschke H, Gores GJ, Cederbaum AI, Hinson JA, Pessayre D, Lemasters JJ. Mechanisms of hepatotoxicity. Toxicol Sci 2002; 65: 166-76.
25. Mitchell JR, Jollow DJ, Potter WZ, Gillette JR, Brodie BB. Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione. J Pharmacol Exp Ther 1973; 187: 211-7.
26. Heard KJ. Acetylcysteine for acetaminophen poisoning. N Engl J Med 2008; 359: 285-92.
27. Woods HF, Connor H. Metabolic acidosis in paracetamol poisoning. (letter). Br Med J (Clin Res Ed) 1982; 285: 1208.
28. Gray TA, Buckley BM, Vale JA. Hyperlactataemia and metabolic acidosis following paracetamol overdose. Q J Med 1987; 65: 811-21.
29. Record CO, Iles RA, Cohen RD, Williams R. Acid-base and metabolic disturbances in fulminant hepatic failure. Gut 1975; 16: 144-9.
30. De Backer D. Lactic acidosis. Minerva Anestesiol 2003; 69: 281-4.
31. Nichol AD, Egi M, Pettila V, Bellomo R, French C, Hart G, Davies A, Stachowski E, Reade MC, Bailey M, Cooper DJ. Relative hyperlactatemia and hospital mortality in critically ill patients: a retrospective multi-centre study. Crit Care 2010; 14: R25.
32. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M, Early Goal-Directed Therapy Collaborative Group. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345: 1368-77.
33. Vale JA, Meredith TJ. Metabolic acidosis in paracetamol poisoning. (letter). Br Med J (Clin Res Ed) 1982; 285: 1208.
34. Williams M, Wagstaff A, Ryan D. Metabolic acidosis in paracetamol poisoning. (letter). Br Med J (Clin Res Ed) 1982; 285: 1208.
35. Zezulka A, Wright N. Severe metabolic acidosis early in paracetamol poisoning. Br Med J (Clin Res Ed) 1982; 285: 851-2.
36. Lieh-Lai MW, Sarnaik AP, Newton JF, Miceli JN, Fleischmann LE, Hook JB, Kauffman RE. Metabolism and pharmacokinetics of acetaminophen in a severely poisoned young child. J Pediatr 1984; 105: 125-8.
37. Zabrodski RM, Schnurr LP. Anion gap acidosis with hypoglycemia in acetaminophen toxicity. Ann Emerg Med 1984; 13: 956-9.
38. Flanagan RJ, Mant TG. Coma and metabolic acidosis early in severe acute paracetamol poisoning. Hum Toxicol 1986; 5: 179-82.
39. Kritharides L, Fassett R, Singh B. Paracetamol-associated coma, metabolic acidosis, renal and hepatic failure. Intensive Care Med 1988; 14: 439-40.
40. Dunn RJ. Massive sulfasalazine and paracetamol ingestion causing acidosis, hyperglycemia, coagulopathy, and methemoglobinemia. J Toxicol Clin Toxicol 1998; 36: 239-42.
41. Koulouris Z, Tierney MG, Jones G. Metabolic acidosis and coma following a severe acetaminophen overdose. Ann Pharmacother 1999; 33: 1191-4.
42. Ashtekar CS, Vyas H. Warning note on a blood gas report leading to diagnosis of acetaminophen overdose. Pediatr Crit Care Med 2003; 4: 370-1.
43. Ala A, Schiano T, Burroughs A, Keshav S. Recognition of nonhepatic coma in the setting of acetaminophen overdose. Dig Dis Sci 2004; 49: 1977-80.
44. Ryan JDV. Survival after marked hyperlactaemia. Anaesthesia 2006; 61: 512-3.
45. Bourdeaux C, Bewley J. Death from paracetamol overdose despite appropriate treatment with N-acetylcysteine. Emerg Med J 2007; 24: e31.
46. Wiegand TJ, Margaretten M, Olson KR. Massive acetaminophen ingestion with early metabolic acidosis and coma: treatment with IV NAC and continuous venovenous hemodiafiltration. Clin Toxicol (Phila) 2010; 48: 156-9.
47. Lien D, Mader TJ. Survival from profound alcohol-related lactic acidosis. J Emerg Med 1999; 17: 841-6.
48. Zosel A, Egelhoff E, Heard K. Severe lactic acidosis after an iatrogenic propylene glycol overdose. Pharmacotherapy 2010; 30: 219.
49. Steelman R, Goodman A, Biswas S, Zimmerman A. Metabolic acidosis and coma in a child with acetaminophen toxicity. Clin Pediatr (Phila) 2004; 43: 201-3.
50. Al-Jubouri MA. Metabolic acidosis and coma after acetaminophen ingestion. Ann Emerg Med 1999; 34: 685.
51. Hodgman MJ, Horn JF, Stork CM, Marraffa JM, Holland MG, Cantor R, Carmel PM. Profound metabolic acidosis and oxoprolinuria in an adult. J Med Toxicol 2007; 3: 119-24.
52. Pitt JJ, Hauser S. Transient 5-oxoprolinuria and high anion gap metabolic acidosis: clinical and biochemical findings in eleven subjects. Clin Chem 1998; 44: 1497-503.
53. Brooker G, Jeffery J, Nataraj T, Sair M, Ayling R. High anion gap metabolic acidosis secondary to pyroglutamic aciduria (5-oxoprolinuria): association with prescription drugs and malnutrition. Ann Clin Biochem 2007; 44: 406-9.
54. Dempsey GA, Lyall HJ, Corke CF, Scheinkestel CD. Pyroglutamic acidemia: a cause of high anion gap metabolic acidosis. Crit Care Med 2000; 28: 1803-7.
55. Fenves AZ, Kirkpatrick HM, Patel VV, Sweetman L, Emmett M. Increased anion gap metabolic acidosis as a result of 5-oxoproline (pyroglutamic acid): a role for acetaminophen. Clin J Am Soc Nephrol 2006; 1: 441-7.
56. Peter JV, Rogers N, Murty S, Gerace R, Mackay R, Peake SL. An unusual cause of severe metabolic acidosis. Med J Aust 2006; 185: 223-5.
57. Rolleman EJ, Hoorn EJ, Didden P, Zietse R. Guilty as charged: unmeasured urinary anions in a case of pyroglutamic acidosis. Neth J Med 2008; 66: 351-3.
58. Humphreys BD, Forman JP, Zandi-Nejad K, Bazari H, Seifter J, Magee CC. Acetaminophen-induced anion gap metabolic acidosis and 5-oxoprolinuria (pyroglutamic aciduria) acquired in hospital. Am J Kidney Dis 2005; 46: 143-6.
59. Yale SH, Mazza JJ. Anion gap acidosis associated with acetaminophen. Ann Intern Med 2000; 133: 752-3.
60. Mayatepek E. 5-oxoprolinuria in patients with and without defects in the gamma-glutamyl cycle. Eur J Pediatr 1999; 158: 221-5.
61. Ortolani O, Conti A, De Gaudio AR, Moraldi E, Cantini Q, Novelli G. The effect of glutathione and N-acetylcysteine on lipoperoxidative damage in patients with early septic shock. Am J Respir Crit Care Med 2000; 161: 1907-11.
62. Prescott LF, Illingworth RN, Critchley JA, Stewart MJ, Adam RD, Proudfoot AT. Intravenous N-acetylcystine: the treatment of choice for paracetamol poisoning. Br Med J 1979; 2: 1097-100.
63. Pond SM, Tong TG, Kaysen GA, Menke DJ, Galinsky RE, Roberts SM, Levy G. Massive intoxication with acetaminophen and propoxyphene: unexpected survival and unusual pharmacokinetics of acetaminophen. J Toxicol Clin Toxicol 1982; 19: 1-16.
64. Vale JA, Proudfoot AT. Paracetamol (acetaminophen) poisoning. Lancet 1995; 346: 547-52.
65. Forsythe SM, Schmidt GA. Sodium bicarbonate for the treatment of lactic acidosis. Chest 2000; 117: 260-7.
66. Gehlbach BK, Schmidt GA. Bench-to-bedside review: treating acid-base abnormalities in the intensive care unit - the role of buffers. Crit Care 2004; 8: 259-65.
67. Nakashima K, Yamashita T, Kashiwagi S, Nakayama N, Kitahara T, Ito H. The effect of sodium bicarbonate on CBF and intracellular pH in man: stable Xe-CT and 31P-MRS. Acta Neurol Scand Suppl 1996; 166: 96-8.
68. Stacpoole PW, Wright EC, Baumgartner TG, Bersin RM, Buchalter S, Curry SH, Duncan CA, Harman EM, Henderson GN, Jenkinson S. A controlled clinical trial of dichloroacetate for treatment of lactic acidosis in adults. The dichloroacetate-lactic acidosis study group. N Engl J Med 1992; 327: 1564-9.
69. Mutimer DJ, Ayres RC, Neuberger JM, Davies MH, Holguin J, Buckels JA, Mayer AD, McMaster P, Elias E. Serious paracetamol poisoning and the results of liver transplantation. Gut 1994; 35: 809-14.
70. Record CO, Chase RA, Williams R, Appleton D. Disturbances of lactate metabolism in patients with liver damage due to paracetamol overdose. Metabolism 1981; 30: 638-43.
71. Landry DW, Oliver JA. The pathogenesis of vasodilatory shock. N Engl J Med 2001; 345: 588-95.
72. O'Grady JG, Wendon J, Tan KC, Potter D, Cottam S, Cohen AT, Gimson AE, Williams R. Liver transplantation after paracetamol overdose. BMJ 1991; 303: 221-3.
73. O'Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989; 97: 439-45.
74. Mahadevan SBK, McKiernan PJ, Davies P, Kelly DA. Paracetamol induced hepatotoxicity. Arch Dis Child 2006; 91: 598-603.
75. Bailey B, Amre DK, Gaudreault P. Fulminant hepatic failure secondary to acetaminophen poisoning: a systematic review and meta-analysis of prognostic criteria determining the need for liver transplantation. Crit Care Med 2003; 31: 299-305.
76. Riordan SM, Williams R. Use and validation of selection criteria for liver transplantation in acute liver failure. Liver Transpl 2000; 6: 170-3.
77. Anand AC, Nightingale P, Neuberger JM. Early indicators of prognosis in fulminant hepatic failure: an assessment of the King's criteria. J Hepatol 1997; 26: 62-8.
78. Shakil AO, Kramer D, Mazariegos GV, Fung JJ, Rakela J. Acute liver failure: clinical features, outcome analysis, and applicability of prognostic criteria. Liver Transpl 2000; 6: 163-9.
79. Riordan SM, Williams R. Blood lactate and outcome of paracetamol-induced acute liver failure. Lancet 2002; 360: 573.
80. Schmidt LE, Larsen FS. Blood lactate as a prognostic marker in acetaminophen-induced acute liver failure. Hepatology 2003; 37: 1199-201.
81. Schmidt LE, Larsen FS. Prognostic implications of hyperlactatemia, multiple organ failure, and systemic inflammatory response syndrome in patients with acetaminophen-induced acute liver failure. Crit Care Med 2006; 34: 337-43.
82. Dabos KJ, Newsome PN, Parkinson JA, Davidson JS, Sadler IH, Plevris JN, Hayes PC. A biochemical prognostic model of outcome in paracetamol-induced acute liver injury. Transplantation 2005; 80: 1712-7.
83. Joint Formulary Committee of the British Medical Association and the Royal Pharmaceutical Society of Great Britain. British National Formulary 59. 2010.
84. Middleton P, Kelly AM, Brown J, Robertson M. Agreement between arterial and central venous values for pH, bicarbonate, base excess, and lactate. Emerg Med J 2006; 23: 622-4.
85. Treger R, Pirouz S, Kamangar N, Corry D. Agreement between central venous and arterial blood gas measurements in the intensive care unit. Clin J Am Soc Nephrol 2010; 5: 390-4.
86. Kelly AM, McAlpine R, Kyle E. Venous pH can safely replace arterial pH in the initial evaluation of patients in the emergency department. Emerg Med J 2001; 18: 340-2.
87. Gallagher E, Rodriguez K, Touger M. Agreement between peripheral venous and arterial lactate levels. Ann Emerg Med 1997; 29: 479-83.